Capital Area Research is a clinical research site located in Camp Hill, Pennsylvania, United States 17011.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Capital Area Research has participated in 53 clinical trials with 17 currently active.
Therapeutic areas: Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).
Sponsors: Duke University, Eli Lilly and Company, Bristol-Myers Squibb.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Camp Hill
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Area Research has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Area Research has 53 clinical trials on record, with 17 currently active. Their work covers Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Atherosclerotic Cardiovascular Disease (ASCVD).
Capital Area Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.